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An effective plasma membrane 
proteomics approach for small 
tissue samples
Katrien Smolders1, Nathalie Lombaert1, Dirk Valkenborg2,3,4, Geert Baggerman2,3 & 
Lutgarde Arckens1
Advancing the quest for new drug targets demands the development of innovative plasma 
membrane proteome research strategies applicable to small, functionally defined tissue samples. 
Biotinylation of acute tissue slices and streptavidin pull-down followed by shotgun proteomics 
allowed the selective extraction and identification of >1,600 proteins of which >60% are associated 
with the plasma membrane, including (G-protein coupled) receptors, ion channels and transporters, 
and this from mm3-scale tissue.
The plasma membrane (PM) physically separates a cell from its external environment and is composed 
out of a lipid bilayer and associated proteins1–3. The PM proteome is very dynamic because of extensive 
trafficking between the PM and the endomembrane compartment of eukaryotic cells via exocytosis, 
endocytosis and recycling processes4,5. PM proteins (PMPs) like (G-protein coupled) receptors, ion chan-
nels and transporters are crucial for a wide variety of fundamental physiological processes6. Targeted 
profiling of this PM proteome, and specifically the proteome exposed at the cell surface, is key to e.g. 
the identification of cell surface biomarkers or the isolation of tissue-specific cell types2,7–9. Their role in 
cell-cell interactions, molecular transport and signalling explains their potential as important therapeutic 
targets1,10,11.
PMPs exist in two main forms, the integral cell surface proteins spanning the lipid bilayer and the 
peripheral proteins, anchored to the PM1. This heterogeneity, the low overall abundance and hydrophobic 
nature, which results in poor solubility, few trypsin cleavage sites and difficult accessibility for proteases, 
make proteomic analysis of PMPs challenging1,12. Traditional isolation of PMPs from biological tissue 
samples by subcellular fractionation based on ultracentrifugation suffers from weak enrichment and 
contamination from other cellular compartments1,7. It also requires high sample loads, being a major 
disadvantage particularly in e.g. the field of neuroscience research where, usually, sample quantities are 
limited6,13.
It has been demonstrated that biotinylation of cell surface-exposed proteins followed by affinity purifi-
cation from cell lines or cell cultures offers a usable alternative to the classical ultracentrifugation for the 
specific extraction and enrichment of PMPs3,7,14,15. In 2003, Thomas-Crusells and colleagues developed 
and optimized a comparable method for the biotinylation of such cell surface proteins in acute brain 
slices16. This, in combination with standard immunoblotting for predefined PMPs17–19, created the oppor-
tunity to study PMP trafficking in a more natural and physiologically relevant experimental setting16,20. 
Simultaneous ex vivo slice experiments such as electrophysiological recordings can be performed16. To 
our knowledge, biotinylation of acute tissue slices in conjunction with the proteomic profiling of the 
PM proteome has not yet been reported. Nevertheless, it holds the potential to solve both the problem 
of poor extraction efficiency and of high sample consumption characteristic to the more common tissue 
extraction protocols based on ultracentrifugation used in plasma membrane proteomics today.
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Results and Discussion
In this study, we performed an ‘acute slice biotinylation assay’ (ASBA) on mouse coronal brain slices 
(Fig.  1a–d) followed by streptavidin pull-down to separate cell surface-associated proteins in a sub-
fraction termed the ‘PMP enriched fraction’, from the rest of the proteome termed the ‘wash-through 
fraction’ (Fig.  1e). Traditionally, biotinylation of acute slices and affinity purification is used in combi-
nation with immunoblotting to investigate trafficking of receptors and transporters in and out the PM 
in anatomically or functionally delineated regions of interest in a tissue16 such as mouse visual cortex in 
the forebrain17. With the intention to verify the applicability of ASBA in combination with proteomic 
analysis independent of a priori assumptions about the identity of PMPs of potential biological interest, 
and to a lot smaller tissue samples, we also isolated mouse visual cortex tissue (Fig.  1c; red), but on 
mm3-scale as study sample.
To judge the reproducibility of ASBA and streptavidin pull-down, a total protein stain was per-
formed on 1 μ g of proteins separated on SDS-PAGE belonging to the PMP enriched fractions and the 
wash-through fractions (Fig.  1f) derived from 5 different brain samples. The resulting pattern of pro-
tein bands, with a predominant location in the higher Mw regions, appeared identical for each of the 
5 PMP enriched fractions and differed markedly from the pattern of protein bands, identical between 
Figure 1. Workflow for plasma membrane proteomic analysis of small tissue samples. (a) Dissect organ 
of interest, like mouse brain, in artificial cerebrospinal fluid (aCSF). (b) Make slices, allow recovery, label 
with EZ-Link Sulfo-NHS-SS-Biotin. After quenching, dissect region of interest like the visual cortex (c, red) 
and mechanically homogenize (d). (e) Separate the plasma membrane protein (PMP) enriched fraction (P) 
from the rest of the proteome (wash-through, W) by streptavidin pull-down. Panel (f) illustrates SDS-PAGE 
for P and W. After digestion (g) analyse the protein samples and annotate (h). c adapted from30. Scale bar: 
1 mm.
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all 5 wash-through fractions. For each of these protein samples we calculated the relative proportion of 
protein quantity in its PMP enriched fraction to the initial total protein content, that is the sum of the 
wash-through and PMP enriched fraction. The percentage of proteins in the PMP enriched fraction from 
each of the extracts ranged between 6.0 and 7.2%.
The clear dissimilarity in band pattern between a PMP enriched fraction and wash-through of one 
and the same ASBA extract (Fig.  1f), is indicative of a clear difference between the proteins retained 
on the Streptavidin agarose resin versus those in the eluent. This prompted us to identify the proteins 
present in the two fractions of each of the 5 brain samples using shotgun proteomics (Table  1 and 
Supplementary Data 1 and 2). An intermediate step of tube-gel digestion on 25 μ g proteins per fraction 
improved solubilisation and digestion efficiency of membrane proteins21, and facilitated the removal of 
detergents prior to mass spectrometric analysis of 1 μ g samples (Fig. 1g,h). Next, we used IPA to catego-
rize each identified protein present in the 5 PMP enriched fractions into their subcellular compartment, 
as an extra validation of the capability of the ASBA method to truly enrich PMPs from a proteomic 
sample. The percentage of proteins categorised as PMPs by IPA in the 5 separate PMP enriched fractions 
ranged between 26.8 and 28.8%, illustrating enrichment in and reproducibility of our workflow (Table 1).
For a more detailed analysis of the plasma membrane proteome, we then merged all identifications 
of the 5 PMP enriched fractions together into 1 protein list. We also merged the identification lists of 
the 5 wash-through fractions. This resulted in respectively 1,698 and 2,872 discrete proteins that were 
identified in that PMP enriched fraction and wash-through fraction (Table 1). Of these 1,698 proteins 
identified in this PMP enriched fraction, IPA successfully annotated 1,625 proteins. Out of these 1,625, 
417 proteins or 25.7% were classified as PMP (Table 1 and 2). Because IPA only provides one subcellular 
localization per protein and does not consider the additional cellular compartments in which a pro-
tein can occur15, secondary annotations were also checked in IPA and DAVID, in combination with an 
intensive literature search6. As such, a large number of proteins (372) could be additionally assigned to 
potentially reside in association with (peripheral proteins) or even be fully embedded within the plasma 
membrane (integral proteins), leading to a total of 789 or 48.6% of PMPs in the PMP enriched fraction 
(Table 2, Supplementary Table 1, Fig. 1h). Of note, this additional analysis classified an even larger subset 
of PMPs as ion channel, transmembrane receptor, transporter or G-protein coupled receptor (Table  2 
and Supplementary Table 1). Together with these 789 annotated PMPs, another 8 proteins located at 
the cell surface (0.5%), 163 at the cellular membrane (10.0%) and 51 proteins in the extracellular space 
(3.1%) (Supplementary Table 2), this accounts for 1,011 or 62.2% proteins in the PMP enriched fraction 
that have been reported to reside in or near the cell surface (Fig. 1h). The remaining 37.8% proteins in 
the PMP enriched fraction might be the result of co-purification of large intracellular complexes, with 
the biotinylated proteins still associated to the plasma membrane or with the readily releasable vesicle 
pools. These proteins deserve attention in future research to either confirm or exclude their capacity to 
potentially reside at the PM. In sum, our yields are in agreement with or even higher than recent PMP 
enrichment studies based on aqueous two-phase affinity partitioning of a much larger tissue sample, a 
complete rat or mouse cerebellum13,22, or on biotinylation and affinity purification of cell surface proteins 
of cultured mouse cortical neurons14.
sample
# of ≠ 
IDs
# of ≠ IDs 
annotated 
by IPA
# of PMPs 
(1° IPA)
% of 
PMPs
PMP ENRICHED FRACTION
1 968 934 250 26.8
2 927 896 242 27.0
3 872 846 244 28.8
4 922 890 254 28.5
5 993 968 270 27.9
merge 1,2,3,4,5 1,698 1,625 417 25.7
WASH-THROUGH FRACTION
1 1,594
2 1,587
3 1,640
4 1,494
5 1,584
merge 1,2,3,4,5 2,872
Table 1.  Percentage of PMPs in the 5 PMP enriched fractions.
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Accession no. Protein name
identified in 
# of samples
ION CHANNEL
 IPI00113149 syntaxin 1B 5
 IPI00113244 tweety family member 1 4
 IPI00113772 gamma-aminobutyric acid (GABA) A receptor, alpha 1 5
 IPI00122300 calcium channel, voltage-dependent, gamma subunit 3 5
 IPI00122974 glycoprotein M6A 5
 IPI00129491 potassium voltage-gated channel, Shal-related subfamily, member 2 4
 IPI00129774 potassium voltage-gated channel, shaker-related subfamily, member 2 5
 IPI00130253 calcium channel, voltage-dependent, alpha 2/delta subunit 3 5
 IPI00130546 gamma-aminobutyric acid (GABA) A receptor, beta 3 5
 IPI00136965 glutamate receptor, ionotropic, AMPA 1 5
 IPI00315359 potassium voltage-gated channel, shaker-related subfamily, beta member 2 4
 IPI00322698 transient receptor potential cation channel, subfamily V, member 2 5
 IPI00323554 gamma-aminobutyric acid (GABA) A receptor, beta 2 5
 IPI00338309 ryanodine receptor 2 (cardiac) 5
 IPI00410982 calcium channel, voltage-dependent, alpha 2/delta subunit 1 5
 IPI00461322 annexin A7 5
 IPI00608056 glutamate receptor, ionotropic, N-methyl D-aspartate 1 5
 IPI00625961 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 1
 IPI00652101 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 5
 IPI00673613 sodium channel, voltage-gated, type I, alpha subunit 1
 IPI00751228 glutamate receptor, ionotropic, AMPA 2 5
 IPI00761641 sodium channel, voltage-gated, type II, alpha subunit 5
 IPI00877256 tweety family member 3 5
 IPI00895035 glutamate receptor, ionotropic, AMPA 3 5
 IPI00930821 potassium channel tetramerization domain containing 12 2
 IPI01019157 potassium channel tetramerization domain containing 12 2
 IPI00110601 gamma-aminobutyric acid (GABA) A receptor, alpha 3 3
 IPI00119283 gamma-aminobutyric acid (GABA) A receptor, beta 1 1
 IPI00119615 potassium inwardly-rectifying channel, subfamily J, member 3 1
 IPI00120318 glutamate receptor, ionotropic, kainate 3 1
 IPI00128826 calcium channel, voltage-dependent, gamma subunit 8 4
 IPI00130455 FXYD domain containing ion transport regulator 1 4
 IPI00131471 glutamate receptor, ionotropic, AMPA 4 1
 IPI00132786 calcium channel, voltage-dependent, gamma subunit 2 1
 IPI00133980 hyperpolarization activated cyclic nucleotide-gated potassium channel 2 1
 IPI00228358 gamma-aminobutyric acid (GABA) A receptor, gamma 2 3
 IPI00331064 calcium channel, voltage-dependent, R type, alpha 1E subunit 1
 IPI00421206 potassium channel tetramerization domain containing 12 3
 IPI00473235 calcium channel, voltage-dependent, beta 4 subunit 3
 IPI00554917 chloride channel, voltage-sensitive 6 1
 IPI00625414 calcium channel, voltage-dependent, N type, alpha 1B subunit 1
 IPI00751689 calcium channel, voltage-dependent, alpha 2/delta subunit 2 1
 IPI00752080 integrin, alpha V 4
 IPI00775995 calcium channel, voltage-dependent, L type, alpha 1F subunit 1
Continued
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Accession no. Protein name
identified in 
# of samples
 IPI00844657 potassium voltage-gated channel, Shaw-related subfamily, member 3 1
 IPI00874658 gamma-aminobutyric acid (GABA) A receptor, gamma 2 1
 IPI00875552 tweety family member 1 1
 IPI00928524 potassium voltage-gated channel, shaker-related subfamily, beta member 2 1
 IPI00930809 calcium channel, voltage-dependent, gamma subunit 3 1
TRANSMEMBRANE RECEPTOR
 IPI00114939 neuronal pentraxin receptor 5
 IPI00119063 low density lipoprotein receptor-related protein 1 5
 IPI00137311 plexin A1 5
 IPI00229992 plexin B1 5
 IPI00403079 CD47 molecule 5
 IPI00462790 coagulation factor III (thromboplastin, tissue factor) 4
 IPI00463489 opioid binding protein/cell adhesion molecule-like 5
 IPI00473582 ciliary neurotrophic factor receptor 5
 IPI00756275 plexin B2 2
 IPI00876097 plexin A4 5
 IPI00130995 interleukin 18 receptor accessory protein 1
 IPI00313025 scavenger receptor class A, member 3 1
 IPI00315280 semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) 1
 IPI00351062 cholinergic receptor, nicotinic, alpha 9 (neuronal) 1
 IPI00463026 interleukin 1 receptor accessory protein-like 1 1
 IPI00471022 plexin D1 4
 IPI00480518 sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A 1
 IPI00674255 plexin C1 2
 IPI00754710 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 1
 IPI00874523 roundabout, axon guidance receptor, homolog 1 (Drosophila) 2
 IPI00986716 plexin B2 2
 IPI00989396 roundabout, axon guidance receptor, homolog 1 (Drosophila) 1
TRANSPORTER
 IPI00109153 solute carrier family 17 (vesicular glutamate transporter), member 7 5
 IPI00111151 rabphilin 3A 5
 IPI00113869 basigin (Ok blood group) 5
 IPI00114279 solute carrier family 1 (glial high affinity glutamate transporter), member 3 5
 IPI00114641 solute carrier family 3 (amino acid transporter heavy chain), member 2 5
 IPI00121550 ATPase, Na+ /K+ transporting, beta 1 polypeptide 5
 IPI00122048 ATPase, Na+ /K+ transporting, alpha 3 polypeptide 5
 IPI00123704 ATPase, Na+ /K+ transporting, beta 2 polypeptide 5
 IPI00124221 ATPase, Na+ /K+ transporting, beta 3 polypeptide 2
 IPI00125397 solute carrier family 30 (zinc transporter), member 3 1
 IPI00125635 synaptosomal-associated protein, 25 kDa 5
 IPI00126796 solute carrier family 27 (fatty acid transporter), member 4 3
 IPI00127713 ATPase, Ca+ + transporting, plasma membrane 2 5
Continued
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Accession no. Protein name
identified in 
# of samples
 IPI00134191 solute carrier family 2 (facilitated glucose transporter), member 3 5
 IPI00135130 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 5
 IPI00136372 synapsin I 5
 IPI00137194 solute carrier family 16 (monocarboxylate transporter), member 1 1
 IPI00221456 synaptic vesicle glycoprotein 2B 5
 IPI00227928 solute carrier family 6 (neurotransmitter transporter), member 1 4
 IPI00230289 solute carrier family 1 (glial high affinity glutamate transporter), member 2 1
 IPI00268433 solute carrier family 8 (sodium/calcium exchanger), member 1 3
 IPI00308691 solute carrier family 2 (facilitated glucose transporter), member 1 5
 IPI00311682 ATPase, Na+ /K+ transporting, alpha 1 polypeptide 5
 IPI00314289 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 4
 IPI00322156 solute carrier family 38, member 3 5
 IPI00331577 solute carrier family 7 (amino acid transporter light chain, L system), member 5 4
 IPI00403860 neurexin 1 5
 IPI00407692 ATPase, H+ transporting, lysosomal 70 kDa, V1 subunit A 5
 IPI00420244 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 4
 IPI00420569 ATPase, Na+ /K+ transporting, alpha 2 polypeptide 5
 IPI00465769 solute carrier family 12 (potassium/chloride transporter), member 5 5
 IPI00555118 solute carrier family 4, sodium bicarbonate transporter, member 10 5
 IPI00556827 ATPase, Ca+ + transporting, plasma membrane 1 5
 IPI00621162 ATPase, Ca+ + transporting, plasma membrane 3 3
 IPI00648537 solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 3
 IPI00648633 solute carrier family 44 (choline transporter), member 1 1
 IPI00750917 ATPase, Ca+ + transporting, plasma membrane 4 2
 IPI00754989 solute carrier family 39 (zinc transporter), member 12 5
 IPI00857092 solute carrier family 4 (sodium bicarbonate cotransporter), member 4 5
 IPI00884508 solute carrier family 2 (facilitated glucose transporter), member 1 5
 IPI00890144 solute carrier family 4, sodium bicarbonate cotransporter, member 8 5
 IPI00970455 neurexin 1 5
 IPI00125830 Ly6/neurotoxin 1 2
 IPI00128152 ATP-binding cassette, sub-family B (MDR/TAP), member 1B 3
 IPI00128391 megalencephalic leukoencephalopathy with subcortical cysts 1 1
 IPI00129395 solute carrier family 7 (amino acid transporter light chain, L system), member 5 1
 IPI00135632 solute carrier family 7 (amino acid transporter light chain, L system), member 8 1
 IPI00135678 X-linked Kx blood group 1
 IPI00136867 solute carrier family 6 (neurotransmitter transporter), member 11 3
 IPI00153278 solute carrier family 29 (equilibrative nucleoside transporter), member 4 1
 IPI00165688 solute carrier family 23 (ascorbic acid transporter), member 2 2
 IPI00170146 ATP-binding cassette, sub-family A (ABC1), member 6 1
 IPI00172274 ATP-binding cassette, sub-family C (CFTR/MRP), member 10 1
 IPI00221831 solute carrier family 32 (GABA vesicular transporter), member 1 4
Continued
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 IPI00221932 mal, T-cell differentiation protein 2 (gene/pseudogene) 3
 IPI00230290 solute carrier family 1 (glial high affinity glutamate transporter), member 2 4
 IPI00310247 ANKH inorganic pyrophosphate transport regulator 2
 IPI00338618 ATPase, class V, type 10A 1
 IPI00380273 gap junction protein, alpha 1, 43 kDa 3
 IPI00463589 ATPase, Ca+ + transporting, plasma membrane 4 3
 IPI00623542 solute carrier family 8 (sodium/calcium exchanger), member 1 2
 IPI00648270 solute carrier family 44 (choline transporter), member 1 4
 IPI00652257 solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 1
 IPI00776182 solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 1
 IPI00785299 ATPase, Ca+ + transporting, plasma membrane 3 2
 IPI00788403 ATP-binding cassette, sub-family A (ABC1), member 8 1
 IPI00927968 copine VI (neuronal) 2
G-PROTEIN COUPLED RECEPTOR
 IPI00132061 purinergic receptor P2Y, G-protein coupled, 12 3
 IPI00135659 oligodendrocyte myelin glycoprotein 5
 IPI00136716 glutamate receptor, metabotropic 3 5
 IPI00229528 brain-specific angiogenesis inhibitor 1 4
 IPI00281619 glutamate receptor, metabotropic 1 4
 IPI00407689 gamma-aminobutyric acid (GABA) B receptor, 1 3
 IPI00465871 G protein-coupled receptor 158 5
 IPI00762862 glutamate receptor, metabotropic 2 5
 IPI00816879 latrophilin 1 5
 IPI00881441 latrophilin 3 3
 IPI01018412 gamma-aminobutyric acid (GABA) B receptor, 1 3
 IPI00117887 neuromedin B receptor 1
 IPI00120115 sphingosine-1-phosphate receptor 1 1
 IPI00126064 olfactory receptor 1018 1
 IPI00127181 olfactory receptor 1 1
 IPI00136713 olfactory receptor 157 1
 IPI00153507 vomeronasal 1 receptor 217 1
 IPI00229361 glutamate receptor, metabotropic 6 1
 IPI00269278 G protein-coupled receptor 119 1
 IPI00402890 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I 1
 IPI00470960 glutamate receptor, metabotropic 4 2
 IPI00474802 glutamate receptor, metabotropic 7 2
 IPI00553387 glutamate receptor, metabotropic 5 2
 IPI00605298 G protein-coupled receptor 123 1
 IPI00675087 vomeronasal 2, receptor 32 1
 IPI00755301 gamma-aminobutyric acid (GABA) B receptor, 1 2
 IPI00867815 glutamate receptor, metabotropic 5 3
 IPI00880691 latrophilin 3 2
 IPI00944116 adenosine A3 receptor 1
Continued
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KINASE
 IPI00125147 membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) 5
 IPI00129198 EPH receptor A4 5
 IPI00314316 membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6) 4
 IPI00337992 EPH receptor A4 5
 IPI00351246 membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) 5
 IPI00626797 discs, large homolog 4 (Drosophila) 5
 IPI00672505 discs, large homolog 1 (Drosophila) 5
 IPI00762272 discs, large homolog 2 (Drosophila) 5
 IPI00776413 calcium/calmodulin-dependent serine protein kinase (MAGUK family) 2
 IPI00830221 EPH receptor B4 2
 IPI00830635 EPH receptor A5 3
 IPI00128360 neurotrophic tyrosine kinase, receptor, type 2 4
 IPI00229334 neurotrophic tyrosine kinase, receptor, type 2 1
 IPI00338094 bone morphogenetic protein receptor, type II (serine/threonine kinase) 1
 IPI00474411 TYRO3 protein tyrosine kinase 5
 IPI00474965 epidermal growth factor receptor 3
 IPI00655218 phosphatidylinositol-4-phosphate 5-kinase, type I, gamma 1
 IPI00808241 EPH receptor B1 2
 IPI00875987 G protein-coupled receptor kinase 6 1
 IPI00886325 membrane protein, palmitoylated 1, 55 kDa 1
 IPI00918777 phosphatidylinositol-4-phosphate 5-kinase, type I, gamma 1
PEPTIDASE
 IPI00627016 ADAM metallopeptidase domain 22 5
 IPI00650001 ADAM metallopeptidase domain 23 4
 IPI00798468 ubiquitin specific peptidase 9, X-linked 4
 IPI00881709 dipeptidyl-peptidase 6 5
 IPI00118674 nicastrin 3
 IPI00169524 thyrotropin-releasing hormone degrading enzyme 1
 IPI00408232 ADAM metallopeptidase domain 11 2
 IPI00621146 transmembrane protease, serine 11c 1
 IPI00648033 ADAM metallopeptidase domain 23 1
 IPI00752133 signal peptide peptidase like 2A 1
 IPI00928374 nicastrin 2
 IPI01027504 ubiquitin specific peptidase 9, X-linked 1
 IPI01027684 ubiquitin specific peptidase 9, X-linked 1
PHOSPHATASE
 IPI00115626 phosphatidic acid phosphatase type 2B 2
 IPI00405703 protein tyrosine phosphatase, receptor type, A 1
 IPI00420590 lipid phosphate phosphatase-related protein type 4 5
 IPI00465836 protein tyrosine phosphatase, receptor type, D 5
 IPI00627008 protein tyrosine phosphatase, receptor-type, Z polypeptide 1 5
 IPI00875821 SET binding factor 1 5
Continued
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 IPI00876489 signal-regulatory protein alpha 5
 IPI00915502 protein tyrosine phosphatase, receptor type, S 5
 IPI01027153 protein tyrosine phosphatase, receptor type, D 5
 IPI00110264 protein tyrosine phosphatase, receptor type, F 1
 IPI00336550 protein tyrosine phosphatase, receptor type, A 2
 IPI00399905 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 1
 IPI00475109 protein phosphatase 3, catalytic subunit, beta isozyme 4
 IPI00857748 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 3
 IPI00881167 protein tyrosine phosphatase, receptor type, G 1
TRANSCRIPTION REGULATOR
 IPI00222057 neogenin 1 3
ENZYME
 IPI00115429 gamma-glutamyltransferase 7 5
 IPI00117176 fatty acid amide hydrolase 1
 IPI00120716 guanine nucleotide binding protein (G protein), beta polypeptide 1 5
 IPI00121387 guanine nucleotide binding protein (G protein), alpha 11 (Gq class) 4
 IPI00123058 contactin 1 5
 IPI00126551 DIRAS family, GTP-binding RAS-like 2 5
 IPI00130949 adenylate cyclase 1 (brain) 5
 IPI00133218 ADP-ribosylation factor-like 8B 3
 IPI00138716 RAP2B, member of RAS oncogene family 5
 IPI00162780 guanine nucleotide binding protein (G protein), beta polypeptide 2 1
 IPI00222125 catechol-O-methyltransferase domain containing 1 2
 IPI00228618 guanine nucleotide binding protein (G protein), q polypeptide 5
 IPI00230192 guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O 4
 IPI00230193 guanine nucleotide binding protein (G protein), alpha z polypeptide 5
 IPI00230194 guanine nucleotide binding protein (G protein), gamma 2 2
 IPI00309113 neuroligin 1 4
 IPI00378017 guanine nucleotide binding protein (G protein), beta 5 5
 IPI00396701 RAP2A, member of RAS oncogene family 5
 IPI00467152 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 5
 IPI00468605 neuroligin 2 5
 IPI00649388 guanine nucleotide binding protein (G protein), alpha 13 2
 IPI00816946 gephyrin 4
 IPI00858047 monoglyceride lipase 5
 IPI00881278 adenylate cyclase 9 5
 IPI00928550 gamma-glutamyltransferase 7 5
 IPI00929787 trans-2,3-enoyl-CoA reductase 5
 IPI00115546 guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O 1
 IPI00123623 hyaluronan synthase 1 1
 IPI00126501 carbonic anhydrase XIV 5
Continued
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 IPI00128097 adenylate cyclase 4 1
 IPI00225670 gephyrin 1
 IPI00228295 contactin 4 1
 IPI00272230 RAB39B, member RAS oncogene family 1
 IPI00315334 neuroblastoma RAS viral (v-ras) oncogene homolog 1
 IPI00331267
ABO blood group (transferase A, alpha 
1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 
1-3-galactosyltransferase)
1
 IPI00377311 diacylglycerol lipase, alpha 1
 IPI00403586 neutral cholesterol ester hydrolase 1 1
 IPI00649078 SH3-domain GRB2-like 2 2
 IPI00652606 RAB2B, member RAS oncogene family 2
 IPI00749677 dynamin 2 1
 IPI00750570 GNAS complex locus 5
 IPI00758356 guanine nucleotide binding protein (G protein), beta polypeptide 2 4
 IPI00856692 diacylglycerol lipase, alpha 1
 IPI00876486 ectonucleotide pyrophosphatase/phosphodiesterase 7 1
 IPI00885337 neuroligin 3 1
 IPI00886041 neuroligin 3 1
 IPI00918346 contactin 6 1
 IPI01027614 dynamin 2 1
OTHER
 IPI00109727 Thy-1 cell surface antigen 5
 IPI00110451 SLIT and NTRK-like family, member 1 5
 IPI00115827 glioblastoma amplified sequence 5
 IPI00117181 flotillin 1 3
 IPI00118020 cell adhesion molecule 3 4
 IPI00118075 microtubule-associated protein 2 5
 IPI00119033 intercellular adhesion molecule 5, telencephalin 5
 IPI00119130 BTB (POZ) domain containing 17 5
 IPI00119689 adaptor-related protein complex 2, beta 1 subunit 5
 IPI00119870 catenin (cadherin-associated protein), alpha 2 4
 IPI00119970 contactin 2 (axonal) 5
 IPI00120302 leucine-rich, glioma inactivated 1 5
 IPI00120793 prion protein 4
 IPI00120943 cyclin and CBS domain divalent metal cation transport mediator 1 2
 IPI00121378 activated leukocyte cell adhesion molecule 5
 IPI00122971 neural cell adhesion molecule 1 5
 IPI00128022 protocadherin 7 2
 IPI00131376 spectrin, beta, erythrocytic 2
 IPI00134200 leucine rich repeat and Ig domain containing 1 5
 IPI00134492 synapsin II 5
 IPI00136135 catenin (cadherin-associated protein), delta 2 4
 IPI00137331 CAP, adenylate cyclase-associated protein 1 (yeast) 1
 IPI00153840 cell adhesion molecule 4 5
 IPI00221540 ER lipid raft associated 2 1
 IPI00227126 tenascin R 5
Continued
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 IPI00227235 ankyrin 2, brain 4
 IPI00228617 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 5
 IPI00228680 neurexin III 1
 IPI00229299 erythrocyte membrane protein band 4.1-like 3 4
 IPI00229475 junction plakoglobin 2
 IPI00229703 vesicle-associated membrane protein 2 (synaptobrevin 2) 5
 IPI00230151 myelin associated glycoprotein 5
 IPI00230408 microtubule-associated protein tau 2
 IPI00263013 proteolipid protein 1 2
 IPI00274767 glycoprotein M6B 3
 IPI00310916 CD81 molecule 3
 IPI00311405 poliovirus receptor-related 1 (herpesvirus entry mediator C) 5
 IPI00319830 spectrin, beta, non-erythrocytic 1 5
 IPI00322617 neural cell adhesion molecule 2 5
 IPI00323800 neurofilament, medium polypeptide 3
 IPI00329927 neurofascin 4
 IPI00331579 synaptogyrin 3 5
 IPI00338983 contactin associated protein 1 5
 IPI00400180 amphiphysin 4
 IPI00405736 CD81 molecule 1
 IPI00410985 cell adhesion molecule 1 3
 IPI00420467 poliovirus receptor-related 1 (herpesvirus entry mediator C) 5
 IPI00420554 contactin associated protein-like 2 5
 IPI00458574 cadherin 13 5
 IPI00461199 bassoon presynaptic cytomatrix protein 5
 IPI00467747 neuronal growth regulator 1 5
 IPI00471176 hepatic and glial cell adhesion molecule 5
 IPI00474209 synaptosomal-associated protein, 91 kDa 5
 IPI00620207 dematin actin binding protein 1
 IPI00648658 clathrin, light chain A 3
 IPI00649966 synaptosomal-associated protein, 47 kDa 2
 IPI00652675 limbic system-associated membrane protein 5
 IPI00652902 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 5
 IPI00656204 NCK-associated protein 1 5
 IPI00663736 synaptic Ras GTPase activating protein 1 3
 IPI00670856 cadherin 10, type 2 (T2-cadherin) 1
 IPI00675985 potassium channel tetramerization domain containing 16 5
 IPI00719927 protocadherin 1 4
 IPI00751569 DnaJ (Hsp40) homolog, subfamily C, member 5 5
 IPI00753793 spectrin, alpha, non-erythrocytic 1 5
 IPI00756921 tetraspanin 7 5
 IPI00757097 SH3 and multiple ankyrin repeat domains 2 4
 IPI00757771 neuroplastin 5
 IPI00830223 tropomyosin 1, alpha 5
 IPI00831568 L1 cell adhesion molecule 5
 IPI00831624 connector enhancer of kinase suppressor of Ras 2 1
 IPI00848690 lymphocyte antigen 6 complex, locus H 4
Continued
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Accession no. Protein name
identified in 
# of samples
 IPI00850833 cell adhesion molecule 2 4
 IPI00854028 contactin associated protein 1 5
 IPI00855176 protocadherin 9 4
 IPI00857329 neurotrimin 5
 IPI00858209 LanC lantibiotic synthetase component C-like 2 (bacterial) 5
 IPI00869430 CAP, adenylate cyclase-associated protein 1 (yeast) 1
 IPI00882293 membrane bound O-acyltransferase domain containing 7 3
 IPI00882316 CAP, adenylate cyclase-associated protein, 2 (yeast) 5
 IPI00894724 microtubule-associated protein 2 5
 IPI00918899 syntaxin binding protein 5 (tomosyn) 1
 IPI00929916 tenascin R 5
 IPI00990801 regulating synaptic membrane exocytosis 1 2
 IPI01027487 immunoglobulin superfamily, member 8 5
 IPI00112226 angiopoietin-like 1 1
 IPI00118420 stimulated by retinoic acid 6 1
 IPI00121091 proteolipid protein 1 1
 IPI00121627 cleft lip and palate associated transmembrane protein 1 2
 IPI00122032 receptor accessory protein 2 1
 IPI00131762 cyclin and CBS domain divalent metal cation transport mediator 2 1
 IPI00131896 mitochondrial pyruvate carrier 2 1
 IPI00136021 regulating synaptic membrane exocytosis 1 3
 IPI00154057 protocadherin 1 1
 IPI00173032 integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) 1
 IPI00173248 ankyrin 3, node of Ranvier (ankyrin G) 1
 IPI00222908 fibronectin leucine rich transmembrane protein 2 1
 IPI00228632 catenin (cadherin-associated protein), delta 2 1
 IPI00230610 proteolipid protein 1 2
 IPI00230751 catenin (cadherin-associated protein), alpha 2 1
 IPI00273822 lysosomal-associated membrane protein 3 1
 IPI00309419 leucine rich repeat containing 4C 3
 IPI00313492 leucine rich repeat transmembrane neuronal 2 2
 IPI00321348 immunoglobulin superfamily, member 8 2
 IPI00330250 regulating synaptic membrane exocytosis 3 2
 IPI00336313 protein phosphatase 1, regulatory subunit 9A 4
 IPI00338880 neuronal cell adhesion molecule 2
 IPI00346482 cadherin 10, type 2 (T2-cadherin) 1
 IPI00351827 SH3 and multiple ankyrin repeat domains 3 3
 IPI00380242 desmoglein 4 1
 IPI00381088 unc-13 homolog A (C. elegans) 5
 IPI00405986 erythrocyte membrane protein band 4.1-like 1 1
 IPI00420570 neurofascin 1
 IPI00460715 neurexin III 4
 IPI00461212 oxysterol binding protein-like 8 1
 IPI00466076 sidekick cell adhesion molecule 1 1
 IPI00468202 trophoblast glycoprotein 3
 IPI00473188 annexin A8-like 1 1
 IPI00473968 cadherin 10, type 2 (T2-cadherin) 3
Continued
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The efficiency of the presented workflow for the enrichment of PMPs was further validated using the 
DAVID web tool. This tool allows visualization of the specific protein enrichment in the PMP enriched 
and wash-through fractions by a gene ontology enrichment analysis on all protein identifications of each 
fraction relative to a background. The background was built by merging all proteins identified in the 
PMP enriched with those from the wash-through fraction into one background data set. We used the 
functional annotation charts of the DAVID web tool based on cellular component ontology and visual-
ized the results in ReViGO treemaps (Supplementary Fig. 1 and 2). The treemap adapted from ReViGO 
for the PMP enriched fraction (Supplementary Fig. 1) is summarized in Table 3, illustrating an enrich-
ment of proteins associated to the cell surface specific for neuronal cells in the clusters ‘plasma mem-
brane’, ‘plasma membrane part’, ‘ion channel complex’, ‘intrinsic’ and ‘integral component of PM’, and 
the clusters ‘synapse’, ‘synapse part’, ‘neuron projection’, ‘dendritic spine’, and ‘cell junction’. The treemap 
adapted from ReViGO resulting from our wash-through data set (Supplementary Fig. 2) summarized 
in Table  4 shows clusters of proteins associated with different intracellular organelles, especially with 
Accession no. Protein name
identified in 
# of samples
 IPI00648543 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 1
 IPI00648759 stomatin (EPB72)-like 2 5
 IPI00649994 CAP, adenylate cyclase-associated protein 1 (yeast) 2
 IPI00653438 trophoblast glycoprotein 2
 IPI00653674 KRIT1, ankyrin repeat containing 1
 IPI00670114 Ca+ + -dependent secretion activator 1
 IPI00751974 syntrophin, alpha 1 1
 IPI00756961 netrin G2 1
 IPI00762484 Down syndrome cell adhesion molecule like 1 1
 IPI00830145 sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A 2
 IPI00831210 neurofilament, medium polypeptide 2
 IPI00831427 synovial sarcoma, X breakpoint 2 interacting protein 1
 IPI00831714 leucine rich repeat containing 7 4
 IPI00849429 cell adhesion molecule 1 2
 IPI00853863 FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) 2
 IPI00856771 podocalyxin-like 2 1
 IPI00867858 protocadherin-related 15 3
 IPI00876257 clathrin, light chain A 1
 IPI00880812 LanC lantibiotic synthetase component C-like 1 (bacterial) 4
 IPI00889283 SH3 and multiple ankyrin repeat domains 2 1
 IPI00889292 FAT atypical cadherin 3 1
 IPI00921638 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 1
 IPI00921642 ankyrin 2, brain 1
 IPI00928058 FCH domain only 1 1
 IPI00928139 DAB2 interacting protein 1
 IPI00955069 contactin 5 1
 IPI00987809 spectrin, beta, erythrocytic 1
 IPI00988904 fibronectin leucine rich transmembrane protein 2 2
 IPI00989004 cyclin and CBS domain divalent metal cation transport mediator 1 2
 IPI00990422 synaptic Ras GTPase activating protein 1 4
 IPI01008331 desmocollin 3 1
 IPI01008664 receptor accessory protein 2 2
 IPI01027584 flotillin 1 1
Table 2.  417 PMPs in the PMP enriched fraction (1° IPA annotation).
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mitochondrial function and the ‘respiratory chain’. This reflects the high energy demand and oxygen 
consumption of neurons, and thus the high metabolic rate of the tissue under study23–27. Other clus-
ters contain proteins with a role at the envelope, within the endomembrane system, and within the 
membrane-enclosed lumen. Importantly, no clear cluster was suggested for cell surface-associated pro-
teins for the wash-through fraction.
In conclusion, in this report we present the new combination of a procedure for the specific extraction 
of cell surface-associated proteins including PMPs originating from mm3-scale tissue derived from acute 
tissue slice preparations, with proteomic analysis. This reproducible and efficient enrichment method-
ology is undoubtedly applicable to many different tissue types and can significantly contribute to future 
differential plasma membrane proteomics research in many fields of application ranging from neurosci-
ence, cancer, and immunology, to stem cell research.
Methods
Animals. Adult (n = 5) C57Bl/6J mice of either sex were housed under standard laboratory conditions 
with a daily photoperiod of 13 hours light and 11 hours darkness with water and food available ad libitum.
All experiments were approved by the ethical research committee of KU Leuven and were in strict 
accordance with the European Communities Council Directive of 22 September 2010 (2010/63/EU) and 
with the Belgian legislation (KB of 29 May 2013). Every possible effort was made to minimize animal 
suffering and to reduce the numbers of animals.
Acute slice biotinylation assay (ASBA). Mice were killed by cervical dislocation. Brains were rap-
idly dissected in ice-cold (4 °C) artificial cerebrospinal fluid (aCSF; 124 mM NaCl, 4.9 mM KCl, 2 mM 
Cluster representative %
GO Term
 GO:0031224 intrinsic component of membrane 16
 GO:0016021 integral component of membrane 12
 GO:0005886 plasma membrane 6
 GO:0044459 plasma membrane part 4
 GO:0034702 ion channel complex 1
 GO:0031225 anchored component of membrane 1
 GO:0031226 intrinsic component of plasma membrane 1
 GO:0005887 integral component of plasma membrane 1
 GO:0005832 chaperonin-containing T-complex
 GO:0070469 respiratory chain
 GO:0033178 proton transporting two-sector ATPase complex, catalytic domain
 GO:0031090 organelle membrane 4
 GO:0005740 mitochondrial envelope 4
 GO:0044429 mitochondrial part 3
 GO:0042470 melanosome 2
 GO:0048770 pigment granule 2
 GO:0016023 cytoplasmic membrane-bounded vesicle 3
 GO:0031982 vesicle 1
 GO:0031410 cytoplasmic vesicle 1
 GO:0045202 synapse 9
 GO:0044456 synapse part 7
 GO:0045111 intermediate filament cytoskeleton 3
 GO:0005882 intermediate filament 3
 GO:0044430 cytoskeletal part
 GO:0043005 neuron projection 4
 GO:0043197 dendritic spine 1
 GO:0030054 cell junction 4
 GO:0031975 envelope 3
Table 3.  Summary of ReViGO treemap showing the specific enrichment of proteins within the PMP 
enriched fraction.
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MgSO4, 2 mM CaCl2, 1.2 mM KH2PO4, 25.6 mM NaHCO3, and 10 mM D-glucose; pH 7.4) saturated 
with 95% O2 and 5% CO2. Subsequently, each brain was separated in half along the longitudinal fissure, 
and the left hemisphere was cut into 300 μ m-thick coronal slices using a Vibratome (HM 650 V, Prosan). 
A thickness of tissue slices between 300 and 400 μ m is essential to biotinylate an amount of function-
ally healthy and intact cells that will outnumber the sliced ones28,29. Four slices between Bregma level 
–2.70 and –4.16 of each hemisphere were placed in an incubation chamber (65-0076/BSC-PC, Harvard 
Apparatus by Warner Instruments) filled with aCSF and provided with a continuous flow of 95% O2 and 
5% CO2 for 90 min in order to recover.
Next, the sections were put on ice and supplemented with CO2 and O2 throughout the whole bioti-
nylation procedure. They were washed twice in ice-cold aCSF, incubated for 45 min with EZ-Link 
Sulfo-NHS-SS-Biotin (0.5 mg ml−1 in aCSF; Thermo Scientific) and washed twice with ice-cold aCSF 
complemented by 100 μ M lysine (Sigma) to block the remaining reactive Sulfo-NHS-SS-biotin. It has 
already been demonstrated that these tissue slices stay viable with the cells intact during the complete 
process. Incubation on ice during biotin labelling will limit protein internalization to a minimum in 
order to create a snapshot of the cell surface proteome. The Sulfo-NHS-SS-biotin can reach all cell layers 
Cluster representative %
GO Term
 GO:0005739 mitochondrion 21
 GO:0044429 mitochondrial part 12
 GO:0031967 organelle envelope 13
 GO:0031090 organelle membrane 11
 GO:0005829 cytosol 7
 GO:0031982 vesicle 2
 GO:0031410 cytoplasmic vesicle 2
 GO:0016023 cytoplasmic membrane-bounded vesicle 2
 GO:0043228 non-membrane-bounded organelle 2
 GO:0043232 intracellular non-membrane-bounded organelle 2
 GO:0005759 mitochondrial matrix 1
 GO:0015630 microtubule cytoskeleton 1
 GO:0070013 intracellular organelle lumen 1
 GO:0005875 microtubule associated complex 1
 GO:0005768 endosome 1
 GO:0048770 pigment granule 1
 GO:0042470 melanosome 1
 GO:0005874 microtubule
 GO:0005694 chromosome
 GO:0044445 cytosolic part
 GO:0005840 ribosome
 GO:0031975 envelope 13
 GO:0070469 respiratory chain 2
 GO:0019898 extrinsic component of membrane 1
 GO:0016469 proton-transporting two-sector ATPase complex 1
 GO:0009898 cytoplasmic side of plasma membrane 1
 GO:0030529 ribonucleoprotein complex
 GO:0000502 proteasome complex
 GO:0044448 cell cortex part
 GO:0031974 membrane-enclosed lumen 1
 GO:0012505 endomembrane system 1
 GO:0045177 apical part of cell
 GO:0000267 cell fraction
Table 4.  Summary of ReViGO treemap showing the specific enrichment of proteins within the wash-
through fraction.
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of a slice up to 350 μ m-thick after incubation with minimum 100 μ M for at least 45 min. Because of the 
intact cell membranes and the membrane impermeability of the biotin label, cell surface-exposed pro-
teins will be biotinylated and labelling of intracellular proteins will be minimal16, as substantiated with 
our approach and data set.
The sections were washed and kept in ice-cold, saturated aCSF until dissection of the region of interest 
under a binocular microscope (ASZ30E; Bausch & Lomb). The borders of the visual cortex were deter-
mined based on the stereotaxic mouse brain atlas30. For each brain, the dissected visual cortex tissue 
from the four slices was collected in 100 μ L lysis buffer (1% Triton X-100, 0.1% sodium dodecyl sulphate 
(SDS), 1 mM ethylenediaminetetraacetic acid (EDTA), 50 mM NaCl, 20 mM Tris; pH 7.5) and 4 μ l of 
a mix of protease inhibitors (Roche). After mechanical homogenization and centrifugation (10,000g, 
5 min, 4 °C) the supernatant was collected and stored at –80 °C. The total protein concentration of the 5 
biotin-labelled samples was determined according to the QubitTM Quantification Platform (Invitrogen) 
using a QubitTM fluorometer (Invitrogen, Merelbeke, Belgium).
Isolation of plasma membrane proteins. Biotin-labelled proteins were separated from the rest 
of the proteome by a protocol based on biotin’s affinity for streptavidin. For this purpose, 150 μ l of 
at room temperature (RT) calibrated Streptavidin agarose resin (Thermo Scientific) was loaded onto a 
Pierce® Spin Cups - Cellulose Acetate Filter (Thermo Scientific). After centrifugation, the column was 
centrifuged (500 g, 1 min) and washed four times by adding 700 μ l of phosphate-buffered saline (PBS; 
0.1 M H3PO4, 0.15 M NaCl; pH 7.2) and centrifugation (500 g, 1 min). The 5 biotinylated samples, each 
containing ± 500 μ g of proteins extracted from ± 1 mm3 tissue, were loaded onto 5 prepared columns 
and all were shaken for 15 min at RT. After centrifugation (500 g, 1 min), the columns were washed 
three times with 700 μ l PBS. All of the non-biotinylated proteins were eluted during the wash steps 
with the vast majority of proteins eluted in the first wash-through. Next, 5 μ l 2% SDS, 45 μ l 200 mM 
Triethylammonium bicarbonate (TEAB; Fluka Analytical), 45 μ l MilliQ (Merck Millipore) and 5 μ l 
200 mM Tris (2-carboxyethyl) phosphine (TCEP; Thermo Scientific) were added to each column and 
they were incubated for 1 h at 55 °C for denaturation and reduction. Samples were alkylated for 30 min 
in the dark in 5 μ l 375 mM iodoacetamide (IAA; Thermo Scientific), centrifuged (500 g, 1 min) and the 5 
obtained eluents were collected. Subsequently, 25 μ l 200 mM TEAB and 25 μ l MilliQ were added to each 
column, they were centrifuged (500 g, 1 min), each eluent added to the corresponding previous one and 
these 5 combined samples, being the plasma membrane protein (PMP) enriched fractions, were stored 
at –20 °C, together with the 5 first wash-through fractions.
Protein quantity determination. The total protein concentration of the first wash-throughs and the 
PMP enriched fractions, were determined according to the QubitTM Quantification Platform (Invitrogen) 
as described above. For each sample, the relative proportion of protein quantity in the PMP enriched 
fraction was calculated to the total protein content of the initial sample, the wash-through and PMP 
enriched fraction combined. For the calculation of these percentages, original Qubit protein quantitation 
measurements were used and renumbered according to the total volume of each fraction.
Gel-electrophoresis and total protein stain. To 1 μ g protein of each of the wash-throughs and 1 μ g 
protein of each of the PMP enriched fractions, 5 μ l of XT Sample Buffer solution (4x; Bio-Rad) and 1 μ l 
of XT Reducing Agent (20x; Bio-Rad) was added. The protein samples were denatured and reduced for 
10 min on 70 °C. Proteins were separated on a CriterionTM Precast GelXT 4–12% Bis-Tris (Bio-Rad) in 
the CriterionTM Cell (Bio-Rad) system and 4 μ L of the SpectraTM Multicolor High range protein ladder 
(Thermo Scientific) was used as molecular weight standard. Next, we performed a total protein stain with 
Serva Purple (SERVA) according to manufacturer’s instructions. After the staining, the gel was scanned 
with the Bio-Rad ChemiDocTM MP Imaging System.
Proteomic analysis. For the 5 wash-throughs and the 5 PMP enriched fractions, 25 μ g was diluted in 
MilliQ to a total volume of 100 μ L. The samples were subsequently transformed into tube-gels by adding 
25 μ L of Acrylamide/Bis solution (40% 29:1; Bio-Rad), 1 μ l SDS (10%), 0.5 μ l APS (ammonium persul-
fate, 10%; Sigma) and 0.1 μ l Temed (N, N, N’, N’ - Tetramethylethylenediamine; Fluka BioChemika) and 
incubation of 30 min at RT. Peptides were extracted from these tube-gels by in-gel trypsin digestion. The 
tube gels were cut in pieces of approximately 1 mm3. The pieces were washed twice with 50 μ l MilliQ, 
followed by 3 × 50 μ l acetonitrile. After three cycles of hydration with acetonitrile and rehydration with 
100 mM ammonium bicarbonate, the gel pieces were vacuum dried in a vacuum concentrator. To start 
the enzymatic digestion, 25 μ l of a solution containing 5 ng μ l−1 trypsin (Promega), 50 mM ammonium 
bicarbonate and 5 mM calciumchloride was added to each gel piece and placed on 37 °C overnight. 
The next day, the tryptic peptides were extracted using 50 mM ammonium bicarbonate followed by 
an extraction with 50% acetonitrile and 5% formic acid. This step was repeated twice. Afterwards, the 
pooled extracts were vacuum dried and the peptides were stored at –20 °C. The equivalent of 1 μ g of total 
protein was loaded and analysed by nanoLC-mass spectrometry. Liquid chromatography mass spectro-
metric analysis was performed on a Waters nanoAquity LC system connected to a Thermo Scientific 
LTQ Velos Orbitrap mass spectrometer. The equivalent of 2 μ g of total protein of the digested sample 
was dissolved in 20 μ l of 2% acetonitrile in HPLC-grade water. 10 μ l of the sample was loaded onto the 
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trapping column (Pepmap C18 300 μ m x 20 mm, Dionex) with an isocratic flow of 2% acetonitrile in 
water with 0.1% formic acid at a flow rate of 5 μ l min−1. After 2 min, the column-switching valve was 
switched, placing the pre-column online with the analytical capillary column, a Pepmap C18, 3 μ m 75 μ m 
x 150 mm nano column (Dionex). Separation was conducted using a linear gradient from 2% acetonitril 
in water, 0.1% formic acid to 40% acetonitril in water, 0.1% formic acid in 160 min. The flow rate was 
set at 400 nl min−1. The LTQ Orbitrap Velos (Thermo Scientific) was set up in a data dependent MS/MS 
mode where a full scan spectrum (350–5,000 m/z, resolution 60,000) was followed by a maximum of ten 
CID tandem mass spectrum (100 to 2,000 m/z). Peptide ions were selected as the twenty most intense 
peaks of the MS1 scan. Collision induced dissociation (CID) scans were acquired in the LTQ iontrap part 
of the mass spectrometer. The normalized collision energy used was 35% in CID. We applied a dynamic 
exclusion list of 45 s.
Data analysis. Proteome Discoverer 1.3.0.339 (Thermo Scientific) was used as a workflow manager to 
handle the data. The tandem MS data were searched using both SEQUEST and Mascot (Matrix science) 
against the Swissprot database (v 09/2012, 538010 sequences) for Mus musculus taxonomy. All tandem 
mass spectra in the range of 300 Da to 8,000 Da were interpreted.
Monoisotopic peak assignment, charge state determination, co-isolation interference, and delta mass 
calculation between the measured and theoretical monoisotopic masses were determined by Proteome 
Discoverer. The precursor mass tolerance was set at 5 ppm, while fragment mass tolerance was set 
to 0.5 Da. A maximum of two missed cleavages by trypsine was allowed for. A static modification of 
57.021 Da on cysteine was defined to allow for carbamidomethylation. Further, a dynamic modification 
of 15.9955 Da was introduced to account for possible oxidation of methionine. The use of average pre-
cursor masses and average fragment masses was prohibited. Only first ranked PSMs were considered for 
further analysis. The false discovery rate is controlled by a target-decoy approach on a reversed database. 
Peptide spectrum matches were found significant at an FDR of 5%.
Protein discoverer 1.3.0.339 was used to combine the significant peptide annotation from Mascot and 
SEQUEST in a parsimonious protein list.
Protein grouping follows the rule of parsimony. Essentially only the minimal list of proteins that can 
explain all the peptides in the data set is reported.
Ingenuity Pathway Analyis (IPA® , QIAGEN Redwood City, www.qiagen.com/ingenuity) and Database 
of Annotation, Visualization and Integrated Discovery (DAVID, version 6.7) were used for cellular com-
ponent assignment.
The enrichment of proteins in the PMP enriched fraction was investigated by analysing all identifica-
tions within this fraction relative to a background composed of all proteins identified in the wash-through 
and PMP enriched fraction together with DAVID31,32. DAVID summarized the cellular component ontol-
ogy identified via a functional annotation chart and calculated a Fisher exact test for each ontology as 
a measure for enrichment within the fraction. Similarly, information about the enrichment of proteins 
in the wash-through fraction was retrieved. The GO-terms and corresponding p-values with Benjamini 
correction were subsequently submitted to ReViGO, a web server that Reduces and Visualizes long lists 
of Gene Ontology terms33, and visualized in treemaps that cluster ontologies with high semantic simi-
larity. The size of these cluster representatives, which are joined in different superclusters each indicated 
by 1 colour, is proportional to the p-values derived by ReViGO. The treemap figures were then adapted 
by changing the colours of the superclusters.
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